193 related articles for article (PubMed ID: 33415010)
1. Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.
West L; Yin Y; Pierce SR; Fang Z; Fan Y; Sun W; Tucker K; Staley A; Zhou C; Bae-Jump V
Am J Cancer Res; 2020; 10(12):4450-4463. PubMed ID: 33415010
[TBL] [Abstract][Full Text] [Related]
2. Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
Hung WC; Lee DY; Chiang EI; Syu JN; Chao CY; Yang MD; Tsai SY; Tang FY
PLoS One; 2020; 15(11):e0241186. PubMed ID: 33137095
[TBL] [Abstract][Full Text] [Related]
3. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
Yin Y; Sui C; Meng F; Ma P; Jiang Y
Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
[TBL] [Abstract][Full Text] [Related]
4. Polyunsaturated fatty acids induce ovarian cancer cell death through ROS-dependent MAP kinase activation.
Tanaka A; Yamamoto A; Murota K; Tsujiuchi T; Iwamori M; Fukushima N
Biochem Biophys Res Commun; 2017 Nov; 493(1):468-473. PubMed ID: 28882592
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status.
Kato T; Kolenic N; Pardini RS
Nutr Cancer; 2007; 58(2):178-87. PubMed ID: 17640164
[TBL] [Abstract][Full Text] [Related]
6. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase-3 activation.
Sam MR; Ahangar P; Nejati V; Habibian R
Cell Oncol (Dordr); 2016 Feb; 39(1):69-77. PubMed ID: 26671842
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid varies in rat skeletal muscle membranes according to fibre type and provision of dietary fish oil.
Macartney MJ; Peoples GE; Treweek TM; McLennan PL
Prostaglandins Leukot Essent Fatty Acids; 2019 Dec; 151():37-44. PubMed ID: 31756643
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
Lim K; Han C; Dai Y; Shen M; Wu T
Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
[TBL] [Abstract][Full Text] [Related]
10. Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.
Qiu J; Zhao Z; Suo H; Paraghamian SE; Hawkins GM; Sun W; Zhang X; Hao T; Deng B; Shen X; Zhou C; Bae-Jump V
Cancer Biol Ther; 2024 Dec; 25(1):2325130. PubMed ID: 38465855
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids.
Lim K; Han C; Xu L; Isse K; Demetris AJ; Wu T
Cancer Res; 2008 Jan; 68(2):553-60. PubMed ID: 18199552
[TBL] [Abstract][Full Text] [Related]
12. Marine- and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation.
Eser PO; Vanden Heuvel JP; Araujo J; Thompson JT
Mol Clin Oncol; 2013 May; 1(3):444-452. PubMed ID: 24649190
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 Polyunsaturated Fatty Acids Trigger Cell Cycle Arrest and Induce Apoptosis in Human Neuroblastoma LA-N-1 Cells.
So WW; Liu WN; Leung KN
Nutrients; 2015 Aug; 7(8):6956-73. PubMed ID: 26295255
[TBL] [Abstract][Full Text] [Related]
14. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
Menendez JA; Lupu R; Colomer R
Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996
[TBL] [Abstract][Full Text] [Related]
15. NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.
Zhang L; Han J; Jackson AL; Clark LN; Kilgore J; Guo H; Livingston N; Batchelor K; Yin Y; Gilliam TP; Gehrig PA; Sheng X; Zhou C; Bae-Jump VL
J Hematol Oncol; 2016 Sep; 9(1):91. PubMed ID: 27655410
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid-induced apoptosis is mediated by activation of mitogen-activated protein kinases in human cancer cells.
Jeong S; Jing K; Kim N; Shin S; Kim S; Song KS; Heo JY; Park JH; Seo KS; Han J; Wu T; Kweon GR; Park SK; Park JI; Lim K
BMC Cancer; 2014 Jul; 14():481. PubMed ID: 24993937
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
Yee LD; Lester JL; Cole RM; Richardson JR; Hsu JC; Li Y; Lehman A; Belury MA; Clinton SK
Am J Clin Nutr; 2010 May; 91(5):1185-94. PubMed ID: 20335550
[TBL] [Abstract][Full Text] [Related]
18. The induction of apoptosis in pre-malignant keratinocytes by omega-3 polyunsaturated fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) is inhibited by albumin.
Nikolakopoulou Z; Shaikh MH; Dehlawi H; Michael-Titus AT; Parkinson EK
Toxicol Lett; 2013 Apr; 218(2):150-8. PubMed ID: 23391486
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.
Harvey KA; Xu Z; Saaddatzadeh MR; Wang H; Pollok K; Cohen-Gadol AA; Siddiqui RA
J Neurosurg; 2015 Mar; 122(3):547-56. PubMed ID: 25526274
[TBL] [Abstract][Full Text] [Related]
20. The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53.
Shin S; Jing K; Jeong S; Kim N; Song KS; Heo JY; Park JH; Seo KS; Han J; Park JI; Kweon GR; Park SK; Wu T; Hwang BD; Lim K
Biomed Res Int; 2013; 2013():568671. PubMed ID: 23841076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
